From insulin to immunotherapy: A century of discovery
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
Identifying dementia & mild cognitive impairment
Dr Timothy Kwok, Professor at The Chinese University of Hong Kong, shares the development of the Electronic Cognitive Screen (EC-Screen) for population screening of dementia in older people.
Innovation in chronic disease prevention
Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.
Plague: The first pandemic disease
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
Arthritis impacts six million Canadians and counting
Dr Siân Bevan, Chief Science Officer of the Arthritis Society describes how arthritis impacts six million Canadians and counting.
Huntington’s disease: Present concern & therapeutic view
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.
How has COVID-19 affected people with lung conditions?
The impact of COVID-19 has proven that we cannot let people with lung conditions continue to be forgotten, says Dr Alison Cook, Chair of the Taskforce for Lung Health.
The role of the mind in dis-ease
We hear from emotional trauma expert and renowned healer, Antonia Harman about the role of the mind in dis-ease.
Is the UK heading for a “perfect storm” of diabetes referrals?
Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.
Causes and progression of vascular dementia
Helen Green, Dementia Specialist Nurse on Dementia UK’s Admiral Nurse Dementia Helpline, charts the causes and progression of vascular dementia.
Ensuring total infection control in 2021
Jackie Hook, Head Technical Chemist (CChem MRSC) at JLA Ltd underlines the importance of ensuring total infection control in 2021.
UK collaboration will revolutionise rare disease treatment
The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.
Childhood trauma linked to multiple sclerosis development
Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.
Diabetics are concerned about disrupted insulin supplies due to Brexit
Diabetics living in the UK are worried about disruption to insulin supplies as a result of Brexit, according to a new social media study.
Changing mealtimes could prevent type 2 diabetes
In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.
Adaptation after heart transplantation: A framework for the future
Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
New framework to improve diagnosis and treatment of rare diseases
The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.
A new era in cardiac diagnosis
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores how modern technology is helping to diagnose Atrial Fibrillation (AF).
The importance of supporting uniquely able bodied female athletes in uncertain times
Here, Mary Wilson, Paralympic athlete, shares her personal experience and health journey to highlight the importance of supporting disabled female athletes.
The beginning of the end for Type 1 diabetes: A new view from immunotherapy...
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
